Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9FKQ1

Entry ID Method Resolution Chain Position Source
AF-Q9FKQ1-F1 Predicted AlphaFoldDB

10 variants for Q9FKQ1

Variant ID(s) Position Change Description Diseaes Association Provenance
ENSVATH14649478 22 T>A No 1000Genomes
tmp_5_26126256_T_C 33 R>G No 1000Genomes
tmp_5_26126122_T_C,A 77 I>M No 1000Genomes
tmp_5_26125717_G_C 183 C>W No 1000Genomes
tmp_5_26125309_A_T 251 S>T No 1000Genomes
ENSVATH14649469 353 F>I No 1000Genomes
ENSVATH12940069 423 I>V No 1000Genomes
ENSVATH07483391 436 K>N No 1000Genomes
ENSVATH03478555 464 R>K No 1000Genomes
ENSVATH00752877 484 T>A No 1000Genomes

1 associated diseases with Q9FKQ1

[MIM: 618254]: Ciliary dyskinesia, primary, 39 (CILD39)

A form of primary ciliary dyskinesia, a disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia. Some patients exhibit randomization of left-right body asymmetry and situs inversus. Primary ciliary dyskinesia associated with situs inversus is referred to as Kartagener syndrome. CILD39 inheritance is autosomal recessive. {ECO:0000269|PubMed:30388400}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A form of primary ciliary dyskinesia, a disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia. Some patients exhibit randomization of left-right body asymmetry and situs inversus. Primary ciliary dyskinesia associated with situs inversus is referred to as Kartagener syndrome. CILD39 inheritance is autosomal recessive. {ECO:0000269|PubMed:30388400}. Note=The disease is caused by variants affecting the gene represented in this entry.

4 regional properties for Q9FKQ1

Type Name Position InterPro Accession
domain Oxoglutarate/iron-dependent dioxygenase 165 - 275 IPR005123
domain Prolyl 4-hydroxylase, alpha subunit 78 - 274 IPR006620
domain Oxoglutarate/iron-dependent oxygenase, C-terminal degradation domain 304 - 535 IPR019601
domain Prolyl 3,4-dihydroxylase TPA1/OFD1, N-terminal domain 172 - 274 IPR039558

Functions

Description
EC Number
Subcellular Localization
  • Membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

3 GO annotations of molecular function

Name Definition
antiporter activity Enables the active transport of a solute across a membrane by a mechanism whereby two or more species are transported in opposite directions in a tightly coupled process not directly linked to a form of energy other than chemiosmotic energy. The reaction is: solute A(out) + solute B(in) = solute A(in) + solute B(out).
transmembrane transporter activity Enables the transfer of a substance, usually a specific substance or a group of related substances, from one side of a membrane to the other.
xenobiotic transmembrane transporter activity Enables the directed movement of a xenobiotic from one side of a membrane to the other. A xenobiotic is a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical.

1 GO annotations of biological process

Name Definition
xenobiotic detoxification by transmembrane export across the plasma membrane A process that reduces or removes the toxicity of a xenobiotic by exporting it outside the cell.

12 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q05497 YDR338C Uncharacterized transporter YDR338C Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q9SYD6 DTX42 Protein DETOXIFICATION 42 Arabidopsis thaliana (Mouse-ear cress) PR
F4HPH1 DTX22 Protein DETOXIFICATION 22 Arabidopsis thaliana (Mouse-ear cress) PR
F4HQ05 DTX8 Protein DETOXIFICATION 8 Arabidopsis thaliana (Mouse-ear cress) PR
F4I4Q3 DTX32 Protein DETOXIFICATION 32 Arabidopsis thaliana (Mouse-ear cress) PR
O49660 DTX56 Protein DETOXIFICATION 56 Arabidopsis thaliana (Mouse-ear cress) PR
Q9C994 DTX14 Protein DETOXIFICATION 14 Arabidopsis thaliana (Mouse-ear cress) PR
Q9FHB6 DTX16 Protein DETOXIFICATION 16 Arabidopsis thaliana (Mouse-ear cress) PR
Q9FNC1 DTX28 Protein DETOXIFICATION 28 Arabidopsis thaliana (Mouse-ear cress) PR
Q9LPV4 DTX31 Protein DETOXIFICATION 31 Arabidopsis thaliana (Mouse-ear cress) PR
Q9SIA5 DTX1 Protein DETOXIFICATION 1 Arabidopsis thaliana (Mouse-ear cress) PR
Q8W488 DTX21 Protein DETOXIFICATION 21 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MRGGDGEEGS ESRVALLKSP HTAEEDGEGL KDRILVETKK LWQIVGPAIF SRVTTYSMLV
70 80 90 100 110 120
ITQAFAGHLG DLELAAISIV NNVTVGFNFG LLLGMASALE TLCGQAFGAK KYHMLGVYMQ
130 140 150 160 170 180
RSWIVLFFCC VLLLPTYIFT TPVLKFLGQP DDIAELSGVV AIWVIPLHFA FTLSFPLQRF
190 200 210 220 230 240
LQCQLKNRVT AYAAAVALVV HILVCWLFVD GLKLGVVGTV ATISISWWVN VLILLVYSTC
250 260 270 280 290 300
GGCPLTWTGL SSEALTGLWE FLKLSASSGV MLCLENWYYR ILIIMTGNLQ NARIAVDSLS
310 320 330 340 350 360
ICMAINGWEM MIPLAFFAGT GVRVANELGA GNGKGARFAT IVSVTQSLII GLFFWVLIML
370 380 390 400 410 420
LHNQIAWIFS SSVAVLDAVN KLSLLLAFTV LLNSVQPVLS GVAVGSGWQS YVAYINLGCY
430 440 450 460 470 480
YCIGVPLGFL MGWGFKLGVM GIWGGMIFGG TAVQTMILSF ITMRCDWEKE AQKASARINK
WSNTIK